HaemoPlax

N/A

Report date: 2025/03/20 15:41:13
NME

Base Information

Drug NameHaemoPlax
Drug Alias Nameplatelet substitute 1 (Haemostatix)artificial platelet (Haemostatix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerum albumin modulatorsCoagulation factor agonists
TargetsSerum albuminCoagulation factor
Therapy Area/IndicationsHemorrhageThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHaemostatix Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaemostatix Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhageThrombocytopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A